JP2016530329A5 - - Google Patents

Download PDF

Info

Publication number
JP2016530329A5
JP2016530329A5 JP2016542807A JP2016542807A JP2016530329A5 JP 2016530329 A5 JP2016530329 A5 JP 2016530329A5 JP 2016542807 A JP2016542807 A JP 2016542807A JP 2016542807 A JP2016542807 A JP 2016542807A JP 2016530329 A5 JP2016530329 A5 JP 2016530329A5
Authority
JP
Japan
Prior art keywords
patent document
patent application
application publication
pellet
international
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016542807A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016530329A (ja
JP6392355B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/055319 external-priority patent/WO2015038854A1/en
Publication of JP2016530329A publication Critical patent/JP2016530329A/ja
Publication of JP2016530329A5 publication Critical patent/JP2016530329A5/ja
Application granted granted Critical
Publication of JP6392355B2 publication Critical patent/JP6392355B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016542807A 2013-09-13 2014-09-12 ペレット包含錠剤 Active JP6392355B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361877786P 2013-09-13 2013-09-13
US61/877,786 2013-09-13
PCT/US2014/055319 WO2015038854A1 (en) 2013-09-13 2014-09-12 Encased-pellet tablets

Publications (3)

Publication Number Publication Date
JP2016530329A JP2016530329A (ja) 2016-09-29
JP2016530329A5 true JP2016530329A5 (enExample) 2017-08-31
JP6392355B2 JP6392355B2 (ja) 2018-09-19

Family

ID=52666297

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016542807A Active JP6392355B2 (ja) 2013-09-13 2014-09-12 ペレット包含錠剤

Country Status (4)

Country Link
US (1) US9566248B2 (enExample)
EP (1) EP3043779B1 (enExample)
JP (1) JP6392355B2 (enExample)
WO (1) WO2015038854A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116270514B (zh) * 2023-03-22 2024-09-06 北京恒创星远医药科技有限公司 一种微丸片剂及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598458A (en) * 1977-04-01 1981-09-23 Hoechst Uk Ltd Tableting of microcapsules
JP2514078B2 (ja) 1988-08-22 1996-07-10 エスエス製薬株式会社 圧縮成型製剤
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
US5436011A (en) 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
GB9600390D0 (en) 1996-01-09 1996-03-13 Univ London Pharmacy Preparation of tablets
US5780055A (en) 1996-09-06 1998-07-14 University Of Maryland, Baltimore Cushioning beads and tablet comprising the same capable of forming a suspension
US6210716B1 (en) 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
GB9921933D0 (en) 1999-09-17 1999-11-17 Univ Gent Solid shaped articles comprising biologically active substances and a method for their production
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
CA2412173C (en) 2000-06-20 2010-08-17 Sanwa Kagaku Kenkyusho Co., Ltd Nucleated molded article, method of producing the same, and device for producing the same
WO2003026560A1 (en) * 2001-09-26 2003-04-03 Sanwa Kagaku Kenkyusho Co.,Ltd Multi-cored molded article, method of producing the same, and device for producing the same
FR2838647B1 (fr) 2002-04-23 2006-02-17 Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant
WO2004091582A1 (en) * 2003-04-17 2004-10-28 Ipca Laboratories Limited Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them
WO2005097041A1 (ja) * 2004-04-09 2005-10-20 Sanwa Kagaku Kenkyusho Co., Ltd. 有核成型品とその製造方法
ES2509340T3 (es) 2004-08-26 2014-10-17 Kikusui Seisakusho Ltd. Máquina de conformado de compresión rotatoria que utiliza un punzón
US20060263429A1 (en) 2005-05-20 2006-11-23 Hengsheng Feng Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof
EP1834634A3 (en) * 2006-03-08 2007-10-03 Rentschler Pharma GmbH Pharmaceutical multiple-unit composition
WO2007122478A2 (en) * 2006-04-20 2007-11-01 Themis Laboratories Private Limited Multiple unit compositions
CA2677623C (en) * 2007-02-09 2015-04-07 Alphapharm Pty Ltd A dosage form containing two or more active pharmaceutical ingredients in different physical forms
US20100104656A1 (en) 2007-03-20 2010-04-29 Paul Wan Sia Heng Meltable Binder for Melt Granulation and/or Pelletization
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
WO2009153635A1 (en) * 2008-06-19 2009-12-23 University Of Witwatersrand, Johannesburg A chronotherapeutic pharmaceutical dosage form
EP2299983A4 (en) 2008-07-24 2012-10-10 Handa Pharmaceuticals Llc ATYPICAL ANTIPSYCHOTIC FORMULATION STABILIZED
DE102008048729A1 (de) 2008-09-24 2010-03-25 Add Technologies Ltd Advanced Drug Delivery Multipartikuläre Tabletten und Verfahren zur deren Herstellung
WO2010064139A2 (en) 2008-12-04 2010-06-10 Intec Pharma Ltd. Zaleplon gastroretentive drug delivery system
UY32427A (es) * 2009-02-13 2010-09-30 Boheringer Ingelheim Internat Gmbh Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma
ES2713330T3 (es) 2009-12-11 2019-05-21 Sumitomo Dainippon Pharma Co Ltd Comprimido recubierto en seco que se desintegra oralmente
EP2601936A4 (en) * 2010-08-03 2014-03-19 Eisai R&D Man Co Ltd COMPRESSED COMPOSITION
JP2012206978A (ja) * 2011-03-30 2012-10-25 Dainippon Printing Co Ltd 徐放性マイクロカプセル及びその製造方法

Similar Documents

Publication Publication Date Title
CY1120783T1 (el) Ανθεκτικη εναντι παραβιασης και ανθεκτικη εναντι μεταποθηκευσης δοσης φαρμακευτικη μορφη δοσολογιας
WO2020131586A3 (en) Methods for identifying neoantigens
CN109415406A (zh) 羊毛甾醇前药化合物及其制备方法和应用
PH12013502277A1 (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4 methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
CN113412260A (zh) 己酮糖激酶抑制剂及其用途
GT201600142A (es) Composiciones farmacéuticas que comprenden azd9291
PA8842701A1 (es) Granulado que contiene nicotina
NO20091501L (no) Farmasoytiske sammensetninger
BR112016008576A2 (pt) Formulações aquosas estáveis de anticorpos e forma farmacêutica de dosagem unitária
JP2010540547A5 (enExample)
CL2008002479A1 (es) Composicion farmaceutica que comprende: a) una o mas sustancias medicamentosas, b) un lipido, c) un co-lipido y d) un mejorador de flujo; formulacion en polvo seco; procesos de elaboracion.
WO2011143118A3 (en) Alcohol-resistant formulations
CL2015001615A1 (es) Una composicion farmaceutica que comprende vortioxetina y donepezilo junto con un excipiente farmaceuticamente aceptable; y su uso para el tratamiento de disfuncion cognitiva, demencia en la enfermedad de alzheimer, disfuncion cognitiva asociada a la depresion y a la esquizofrenia, entre otras enfermedades.
WO2011141791A3 (en) Extended release formulations of desvenlafaxine base
EA202090913A1 (ru) Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон
AR090975A1 (es) N-etil-4-hidroxil-1-metil-5-(metil(2,3,4,5,6-pentahidroxihexil)amino)-2-oxo-n-fenil-1,2-dihidroquinolina-3-carboxamida
EP3476864A4 (en) ETAR ANTIBODIES, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF
MX2017015322A (es) Composicion farmaceutica oral de isotretinoin.
UA105285C2 (uk) Тверда фармацевтична композиція раміприлу і безилату амлодипіну і її отримання
EA201991286A1 (ru) Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин
WO2013024494A3 (en) Amorphous mixture of lopinavir and ritonavir co-precipitated on copovidone
CL2016000182A1 (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
WO2014111956A3 (en) Sustained release formulations of curcuminoids and method of preparation thereof
MX2015015681A (es) Composicion farmaceutica que comprende fingolimod.